This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Spi Pharma, Inc.. Active years: 2006-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2020
Title: Kalyan S Nuguru: Innovator in Quick-Dissolve Pharmaceutical Solutions
Introduction
Kalyan S Nuguru is a notable inventor based in Mantua, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of quick-dissolve dosage forms. With a total of 4 patents to his name, Nuguru's work is paving the way for advancements in medication delivery systems.
Latest Patents
One of Kalyan S Nuguru's latest patents is focused on a co-processed carbohydrate system designed as a quick-dissolve matrix for solid dosage forms. This innovative invention allows for formulations that are directly compressible into solid dosage forms, which can rapidly and completely dissolve or disintegrate in the oral cavity within 60 seconds. The solid dosage forms produced from this co-processed carbohydrate system are particularly beneficial, as they dissolve or disintegrate quickly when placed in the mouth, enhancing patient compliance and convenience.
Career Highlights
Kalyan S Nuguru is currently associated with Spi Pharma, Inc., where he continues to develop innovative pharmaceutical solutions. His expertise in creating effective and efficient drug delivery systems has positioned him as a key player in the industry.
Collaborations
Throughout his career, Nuguru has collaborated with several professionals, including Gary Telfer Norman and Arun F Amin. These collaborations have contributed to the successful development of his patented technologies.
Conclusion
Kalyan S Nuguru's contributions to the pharmaceutical industry, particularly in the realm of quick-dissolve dosage forms, highlight his innovative spirit and dedication to improving medication delivery. His work continues to influence the field and enhance patient experiences with medication.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
